Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: Systematic review and meta-analysis
Under a Creative Commons license
open access
Keywords
Coronavirus
SARS-CoV-2
Angiotensin-converting enzyme inhibitor
Angiotensin-receptor blocker
Acute respiratory distress syndrome
Acute lung injury
Cited by (0)
© 2020 The Author(s). Published by Elsevier B.V.